Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 645, pseudogene (RN7SL645P)

Target: RN7SL645P
Molecular classification: Other (Pseudogene), Miscellaneous RNA

Overview

RN7SL645P (RNA, 7SL, cytoplasmic 645, pseudogene) is a human pseudogene related to the 7SL RNA, which encodes the RNA component of the signal recognition particle (SRP)[1][3][6][7][8]. The 7SL RNA is important for SRP function, guiding protein synthesis and translocation across cellular membranes[5]. However, RN7SL645P is a pseudogene—meaning it is a truncated, likely nonfunctional copy resulting from a retrotransposed event, and does not code for a functional RNA or protein[7][8]. Most 7SL-like sequences in the human genome are pseudogenes, and RN7SL645P is categorized as such[7][8]. There is currently no evidence linking RN7SL645P to disease, drug interactions, or use as a biomarker[1][3][6]. It is not considered a therapeutic target, receptor, enzyme, transporter, or otherwise relevant for direct clinical intervention.

Other names: RN7SL645PRNA, 7SL, cytoplasmic 645, pseudogene

Biological functions

No direct biological function documented for RN7SL645P specifically[1][3][6][8].Pseudogenes can participate in regulation of gene expression, act as miRNA sponges, and may influence cellular processes, but RN7SL645P has no validated functional role[2][4][7][8].

Disease associations

None specifically documented for RN7SL645P[1][3][6].Some pseudogenes (not RN7SL645P) are implicated in regulation of cell proliferation, cancer, or act as competing endogenous RNAs (ceRNAs), but RN7SL645P has not been linked directly to any disease[2].

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 645, pseudogene (RN7SL645P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 645, pseudogene (RN7SL645P).

Explore the full profile